Lilly says once-weekly Byetta beats competitors-WEB ONLY
Eli Lilly and Co. and two drug-development partners said a once-weekly version of the diabetes medicine Byetta proved better at lowering patients’ blood sugar than two competing drugs. Lilly is working with California-based Amylin Pharmaceuticals Inc. and Massachusetts-based Alkermes Inc. to bring once-weekly Byetta, also called exanatide, to market by 2010. The drug is currently […]